Hydrophobic Interaction Chromatography Viral Clearance Optimization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for effective methods to characterize the viral clearance capacity of hydrophobic interaction chromatography (HIC) to ensure drug safety, particularly in the context of biologics manufacturing, where limited understanding exists regarding viral clearance mechanisms, especially in the flow-through mode of HIC.

Innovation Solution

The proposed solution involves determining the impact of development factors on the viral clearance capacity of HIC through experimental designs for multivariate analysis. This includes adjusting the pH of the sample, optimizing column loading, flow rate, and hydrophobic strength of the HIC resin, as well as building a retrospective viral clearance database to explain mechanisms and justify worst-case conditions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If HIC is used in flow-through mode for antibody purification, then antibody purity is improved, but viral clearance capacity is insufficient and mechanism is unclear

Engineering Contradiction:
Improveantibody purityVSAvoidviral clearance capacity
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

The patent applies parameter changes by systematically varying multiple HIC operating parameters including pH (4.2-8.0), buffer concentration (10-200 mM), column loading concentration (40-200 g/L), flow rate (100-300 cm/hr), and hydrophobic strength (weak to strong resin). This multivariate parameter optimization enables identification of conditions that simultaneously achieve high antibody purity and effective viral clearance, resolving the contradiction between purification performance and viral clearance capacity.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces an intermediary approach by using a combination of HIC chromatography and pH treatment as complementary processes. The HIC column acts as an intermediary that selectively binds viruses while allowing antibodies to pass through, with the pH adjustment serving as a supporting mechanism to enhance viral inactivation. This synergistic combination achieves both high purity and effective viral clearance.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If worst-case conditions are selected for viral clearance evaluation, then viral clearance capacity is improved, but process complexity and experimental design difficulty increase

Engineering Contradiction:
Improveviral clearance capacityVSAvoidexperimental design complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent implements feedback through a structured experimental design that iteratively refines worst-case condition selections. Multivariate analysis of experimental results provides feedback on which parameters most significantly impact viral clearance, allowing systematic adjustment of test conditions. This feedback loop enables identification of true worst-case scenarios while managing experimental complexity through data-driven optimization.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent applies dynamics by transitioning from static, fixed-condition viral clearance testing to dynamic, multivariate condition exploration. The experimental design dynamically adjusts multiple parameters simultaneously based on preliminary results, allowing the system to adaptively identify worst-case conditions. This dynamic approach reduces experimental complexity by focusing resources on the most critical parameter combinations.

Inventive Principle:
Principle #15Dynamics

3Loss of information

If multivariate analysis is performed to characterize viral clearance, then understanding of clearance mechanisms is improved, but measurement and analysis complexity increases

Engineering Contradiction:
Improveunderstanding of clearance mechanismsVSAvoidmeasurement and analysis complexity
Core Design Contradiction:
Loss of informationVSDifficulty of detecting and measuring

Solution Approach 1:

The patent applies segmentation by dividing the complex multivariate analysis into manageable segments. The experimental design separates the investigation of individual parameter effects (pH, buffer concentration, loading concentration, flow rate, hydrophobic strength) while also examining their interactions. This segmentation allows systematic exploration of clearance mechanisms without overwhelming complexity, as each parameter can be analyzed independently before integrating results.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent implements universality by developing a multivariate analysis framework that serves multiple functions simultaneously: it characterizes viral clearance capacity, identifies critical parameters, determines worst-case conditions, and elucidates clearance mechanisms. This multi-functional approach consolidates what would otherwise require separate studies into a single integrated analysis, reducing overall measurement and analysis complexity while maximizing information gain.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The approach enhances the understanding of viral clearance mechanisms in HIC, allowing for the optimization of processing conditions to maximize viral clearance and ensure drug safety. By identifying significant development factors and worst-case conditions, this method supports the development of robust viral clearance strategies for biologics manufacturing.

Implementation Method 1

hydrophobic interaction chromatography (HIC)... selective binding of unwanted components while the antibody appears in the flow-through

Methodology Applied
Scientific EffectHydrophobic interaction: Hydrophobe

Implementation Method 2

The processes of virus inactivation or removal include pH treatment, heat treatment, filtration or chromatography

Methodology Applied
Scientific EffectpH treatment:

Data Source

PatentUS20250163134A1Hydrophobic interaction chromatography for viral clearance
Publication Date: 2025.05.22 REGENERON PHARMACEUTICALS INC
  • US20250163134A1 patent drawing
  • US20250163134A1 patent drawing
  • US20250163134A1 patent drawing

AI summary

The present application provides a method for characterizing and/or determining viral clearance capacity of hydrophobic interaction chromatography (HIC) including experimental design for multivariate analysis of viral clearance of HIC. The method provides understanding of the mechanism of the viral clearance using HIC by running a D-Optimal design of experiment including evaluations of multiple factors, such as pH, buffer concentration, column loading concentration, flow rate of column, or hydrophobic strength of the HIC column.